GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Zhong Yuan Bio-Technology Holdings Ltd (OTCPK:ZHYBF) » Definitions » Cash Conversion Cycle

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Cash Conversion Cycle : 142.54 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Zhong Yuan Bio-Technology Holdings Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Zhong Yuan Bio-Technology Holdings's Days Sales Outstanding for the six months ended in Sep. 2023 was 81.61.
Zhong Yuan Bio-Technology Holdings's Days Inventory for the six months ended in Sep. 2023 was 60.93.
Zhong Yuan Bio-Technology Holdings's Days Payable for the six months ended in Sep. 2023 was 0.
Therefore, Zhong Yuan Bio-Technology Holdings's Cash Conversion Cycle (CCC) for the six months ended in Sep. 2023 was 142.54.


Zhong Yuan Bio-Technology Holdings Cash Conversion Cycle Historical Data

The historical data trend for Zhong Yuan Bio-Technology Holdings's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhong Yuan Bio-Technology Holdings Cash Conversion Cycle Chart

Zhong Yuan Bio-Technology Holdings Annual Data
Trend Dec16 Dec17 Dec18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash Conversion Cycle
Get a 7-Day Free Trial 389.64 438.85 1,175.00 705.71 296.76

Zhong Yuan Bio-Technology Holdings Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,173.74 830.56 211.51 897.14 142.54

Competitive Comparison of Zhong Yuan Bio-Technology Holdings's Cash Conversion Cycle

For the Packaged Foods subindustry, Zhong Yuan Bio-Technology Holdings's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhong Yuan Bio-Technology Holdings's Cash Conversion Cycle Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Zhong Yuan Bio-Technology Holdings's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Zhong Yuan Bio-Technology Holdings's Cash Conversion Cycle falls into.



Zhong Yuan Bio-Technology Holdings Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Zhong Yuan Bio-Technology Holdings's Cash Conversion Cycle for the fiscal year that ended in Mar. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=60.14+236.62-0
=296.76

Zhong Yuan Bio-Technology Holdings's Cash Conversion Cycle for the quarter that ended in Sep. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=81.61+60.93-0
=142.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhong Yuan Bio-Technology Holdings  (OTCPK:ZHYBF) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Zhong Yuan Bio-Technology Holdings Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Zhong Yuan Bio-Technology Holdings's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Business Description

Traded in Other Exchanges
N/A
Address
28 Queen’s Road East, Suite 901, Tesbury Centre, Wanchai, Hong Kong, HKG
Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.
Executives
Tingting Chang director, 10 percent owner, officer: CEO RM 1002, 10THFL, LONG HU FUTURE OFFICE, NO. 1 EAST SHI LI PU ROAD, CHAO YANG DISTRICT, BEIJING F4 100024
James M Cassidy director, 10 percent owner, officer: president,secretary,treasurer 215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop director, 10 percent owner, officer: Vice President 9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Headlines

No Headlines